Compare CRIS & USIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRIS | USIO |
|---|---|---|
| Founded | 2000 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.6M | 37.1M |
| IPO Year | 2000 | N/A |
| Metric | CRIS | USIO |
|---|---|---|
| Price | $1.09 | $1.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $16.50 | $4.00 |
| AVG Volume (30 Days) | ★ 111.0K | 45.5K |
| Earning Date | 11-06-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $11,650,000.00 | ★ $83,710,461.00 |
| Revenue This Year | $6.13 | $5.99 |
| Revenue Next Year | $8.44 | $11.65 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 13.56 | 1.46 |
| 52 Week Low | $1.02 | $1.24 |
| 52 Week High | $4.50 | $2.92 |
| Indicator | CRIS | USIO |
|---|---|---|
| Relative Strength Index (RSI) | 35.77 | 46.73 |
| Support Level | $1.14 | $1.41 |
| Resistance Level | $1.41 | $1.50 |
| Average True Range (ATR) | 0.10 | 0.05 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 0.03 | 31.54 |
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Usio Inc is a United States-based company that provides integrated electronic payment services, including credit and debit card-based processing services and transaction processing via the Automated Clearing House, or ACH network to billers and retailers. The Company also has an additional wholly-owned subsidiary, which is the entity for Output Solutions operations.